LU87145A1 - METHOD FOR IMPROVING THE AESTHETIC APPEARANCE OF THE SKIN USING POLYVITAMIN MIXTURES - Google Patents
METHOD FOR IMPROVING THE AESTHETIC APPEARANCE OF THE SKIN USING POLYVITAMIN MIXTURES Download PDFInfo
- Publication number
- LU87145A1 LU87145A1 LU87145A LU87145A LU87145A1 LU 87145 A1 LU87145 A1 LU 87145A1 LU 87145 A LU87145 A LU 87145A LU 87145 A LU87145 A LU 87145A LU 87145 A1 LU87145 A1 LU 87145A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- vitamin
- vitamins
- skin
- cosmetic composition
- oil
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 31
- 239000000203 mixture Substances 0.000 title claims description 49
- 229940088594 vitamin Drugs 0.000 claims abstract description 36
- 229930003231 vitamin Natural products 0.000 claims abstract description 36
- 235000013343 vitamin Nutrition 0.000 claims abstract description 36
- 239000011782 vitamin Substances 0.000 claims abstract description 36
- 239000002537 cosmetic Substances 0.000 claims abstract description 20
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 16
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 16
- 239000011709 vitamin E Substances 0.000 claims abstract description 16
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229960000304 folic acid Drugs 0.000 claims abstract description 8
- 235000019152 folic acid Nutrition 0.000 claims abstract description 8
- 239000011724 folic acid Substances 0.000 claims abstract description 8
- 230000000699 topical effect Effects 0.000 claims abstract description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 20
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 16
- 235000019164 vitamin B2 Nutrition 0.000 claims description 15
- 239000011716 vitamin B2 Substances 0.000 claims description 15
- 239000011675 vitamin B5 Substances 0.000 claims description 15
- 235000009492 vitamin B5 Nutrition 0.000 claims description 15
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 14
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 13
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 12
- 229930003571 Vitamin B5 Natural products 0.000 claims description 12
- 229930003756 Vitamin B7 Natural products 0.000 claims description 12
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 12
- 229960002079 calcium pantothenate Drugs 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 12
- 229960002477 riboflavin Drugs 0.000 claims description 12
- 235000011912 vitamin B7 Nutrition 0.000 claims description 12
- 239000011735 vitamin B7 Substances 0.000 claims description 12
- 229930003471 Vitamin B2 Natural products 0.000 claims description 11
- 235000019155 vitamin A Nutrition 0.000 claims description 11
- 239000011719 vitamin A Substances 0.000 claims description 11
- 229930003427 Vitamin E Natural products 0.000 claims description 10
- 239000002775 capsule Substances 0.000 claims description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 10
- 229940046009 vitamin E Drugs 0.000 claims description 10
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 9
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 8
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 7
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 7
- 229940045997 vitamin a Drugs 0.000 claims description 7
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 7
- 229960003495 thiamine Drugs 0.000 claims description 6
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 6
- 235000010374 vitamin B1 Nutrition 0.000 claims description 6
- 239000011691 vitamin B1 Substances 0.000 claims description 6
- 235000019158 vitamin B6 Nutrition 0.000 claims description 6
- 239000011726 vitamin B6 Substances 0.000 claims description 6
- 229930003451 Vitamin B1 Natural products 0.000 claims description 5
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 5
- 235000019154 vitamin C Nutrition 0.000 claims description 5
- 239000011718 vitamin C Substances 0.000 claims description 5
- 229940011671 vitamin b6 Drugs 0.000 claims description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 claims description 4
- 235000013336 milk Nutrition 0.000 claims description 4
- 239000008267 milk Substances 0.000 claims description 4
- 210000004080 milk Anatomy 0.000 claims description 4
- 235000019160 vitamin B3 Nutrition 0.000 claims description 4
- 239000011708 vitamin B3 Substances 0.000 claims description 4
- 235000013734 beta-carotene Nutrition 0.000 claims description 3
- 239000011648 beta-carotene Substances 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- 239000011573 trace mineral Substances 0.000 claims description 3
- 235000013619 trace mineral Nutrition 0.000 claims description 3
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 3
- 229930003316 Vitamin D Natural products 0.000 claims description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 2
- 239000002366 mineral element Substances 0.000 claims description 2
- 239000011710 vitamin D Substances 0.000 claims description 2
- 235000019166 vitamin D Nutrition 0.000 claims description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 2
- 229940046008 vitamin d Drugs 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims 1
- 239000003921 oil Substances 0.000 description 16
- 210000003491 skin Anatomy 0.000 description 16
- 235000019198 oils Nutrition 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- -1 alkyl sulphates Chemical class 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 239000002304 perfume Substances 0.000 description 4
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 3
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 3
- 229960002216 methylparaben Drugs 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 229960004418 trolamine Drugs 0.000 description 3
- 229940099259 vaseline Drugs 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 2
- 235000011437 Amygdalus communis Nutrition 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 235000019483 Peanut oil Nutrition 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000019485 Safflower oil Nutrition 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 2
- 239000008168 almond oil Substances 0.000 description 2
- 239000010775 animal oil Substances 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 239000010473 blackcurrant seed oil Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 235000004626 essential fatty acids Nutrition 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 229940091250 magnesium supplement Drugs 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- SSZBUIDZHHWXNJ-UHFFFAOYSA-N palmityl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC SSZBUIDZHHWXNJ-UHFFFAOYSA-N 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 239000000312 peanut oil Substances 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 239000003813 safflower oil Substances 0.000 description 2
- 235000005713 safflower oil Nutrition 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 239000010497 wheat germ oil Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- BNIZTLSGVTUSPW-UHFFFAOYSA-N 2-dodecoxyethanamine Chemical compound CCCCCCCCCCCCOCCN BNIZTLSGVTUSPW-UHFFFAOYSA-N 0.000 description 1
- MRBKEAMVRSLQPH-UHFFFAOYSA-N 3-tert-butyl-4-hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1 MRBKEAMVRSLQPH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 206010001488 Aggression Diseases 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 241001246270 Calophyllum Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 208000034657 Convalescence Diseases 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- 241000384507 Hoplostethus Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000016571 aggressive behavior Effects 0.000 description 1
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 1
- 229940063953 ammonium lauryl sulfate Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000021324 borage oil Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229940048851 cetyl ricinoleate Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- ALSTYHKOOCGGFT-UHFFFAOYSA-N cis-oleyl alcohol Natural products CCCCCCCCC=CCCCCCCCCO ALSTYHKOOCGGFT-UHFFFAOYSA-N 0.000 description 1
- 229940090568 combinations of vitamin Drugs 0.000 description 1
- 239000011641 cupric citrate Substances 0.000 description 1
- 235000019855 cupric citrate Nutrition 0.000 description 1
- 239000011642 cupric gluconate Substances 0.000 description 1
- 235000019856 cupric gluconate Nutrition 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical class CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- QVBODZPPYSSMEL-UHFFFAOYSA-N dodecyl sulfate;2-hydroxyethylazanium Chemical compound NCCO.CCCCCCCCCCCCOS(O)(=O)=O QVBODZPPYSSMEL-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 229940116007 ferrous phosphate Drugs 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- XAMHKORMKJIEFW-AYTKPMRMSA-N hexadecyl (z,12r)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/C[C@H](O)CCCCCC XAMHKORMKJIEFW-AYTKPMRMSA-N 0.000 description 1
- VGWSECAZSRHNCT-UHFFFAOYSA-N hexadecyl octadecyl sulfate Chemical compound CCCCCCCCCCCCCCCCCCOS(=O)(=O)OCCCCCCCCCCCCCCCC VGWSECAZSRHNCT-UHFFFAOYSA-N 0.000 description 1
- UFIYKNIUNRVRSI-UHFFFAOYSA-N hexadecyl octadecyl sulfate;sodium Chemical compound [Na].CCCCCCCCCCCCCCCCCCOS(=O)(=O)OCCCCCCCCCCCCCCCC UFIYKNIUNRVRSI-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 239000008173 hydrogenated soybean oil Substances 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910000155 iron(II) phosphate Inorganic materials 0.000 description 1
- SDEKDNPYZOERBP-UHFFFAOYSA-H iron(ii) phosphate Chemical compound [Fe+2].[Fe+2].[Fe+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O SDEKDNPYZOERBP-UHFFFAOYSA-H 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical class CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 235000002538 magnesium citrate Nutrition 0.000 description 1
- 229960005336 magnesium citrate Drugs 0.000 description 1
- 239000004337 magnesium citrate Substances 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- 239000011742 magnesium glycerophosphate Substances 0.000 description 1
- 235000001130 magnesium glycerophosphate Nutrition 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- BHJKUVVFSKEBEX-UHFFFAOYSA-L magnesium;2,3-dihydroxypropyl phosphate Chemical compound [Mg+2].OCC(O)COP([O-])([O-])=O BHJKUVVFSKEBEX-UHFFFAOYSA-L 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000011418 maintenance treatment Methods 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 229940069822 monoethanolamine lauryl sulfate Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N nitrate group Chemical group [N+](=O)([O-])[O-] NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- ZHALDANPYXAMJF-UHFFFAOYSA-N octadecanoate;tris(2-hydroxyethyl)azanium Chemical compound OCC[NH+](CCO)CCO.CCCCCCCCCCCCCCCCCC([O-])=O ZHALDANPYXAMJF-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical class CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- MCAHWIHFGHIESP-UHFFFAOYSA-L selenite(2-) Chemical class [O-][Se]([O-])=O MCAHWIHFGHIESP-UHFFFAOYSA-L 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- GQTHJBOWLPZUOI-FJXQXJEOSA-M sodium D-pantothenate Chemical compound [Na+].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O GQTHJBOWLPZUOI-FJXQXJEOSA-M 0.000 description 1
- 235000019188 sodium D-pantothenate Nutrition 0.000 description 1
- 239000011756 sodium D-pantothenate Substances 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- STDMRMREKPZQFJ-UHFFFAOYSA-H tricopper;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Cu+2].[Cu+2].[Cu+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O STDMRMREKPZQFJ-UHFFFAOYSA-H 0.000 description 1
- 229940029614 triethanolamine stearate Drugs 0.000 description 1
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
- 229960000314 zinc acetate Drugs 0.000 description 1
- 235000013904 zinc acetate Nutrition 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 229960001939 zinc chloride Drugs 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
-1--1-
La présente invention a pour objet une méthode pour améliorer l’aspect esthétique de la peau, notamment du visage, à l'aide d'associations polyvitaminiques.The present invention relates to a method for improving the aesthetic appearance of the skin, in particular of the face, using polyvitamin combinations.
Il est connu que certaines associations équilibrées de vitamines permettent de traiter les sujets présentant une déficience de l'état général due à des fatigues physiques ou intellectuelles, au surmenage ou encore à une alimentation déséquilibrée. Par ailleurs, de tels traitements à base de vitamines sont particulièrement recommandés en période de croissance ou de grossesse et en convalescence.It is known that certain balanced combinations of vitamins make it possible to treat subjects with a deficiency in the general condition due to physical or intellectual fatigue, overwork or even an unbalanced diet. In addition, such vitamin-based treatments are particularly recommended during growth or pregnancy and during convalescence.
Ces mélanges de vitamines qui peuvent également être associés à des sels minéraux et des oligoéléments contiennent, à des doses thérapeutiquement actives, essentiellement les vitamines suivantes: A, D2, Bl, B2, B5, B6, C et E ainsi que de l'acide nicotinique (vitamine PP) et de la biotine (vitamine H).These mixtures of vitamins which can also be associated with mineral salts and trace elements contain, at therapeutically active doses, essentially the following vitamins: A, D2, Bl, B2, B5, B6, C and E as well as acid nicotinic (vitamin PP) and biotin (vitamin H).
Il est également connu, à la suite de nombreuses études scientifiques, que la peau est un tissu particulièrement sensible aux carences nutritionnelles en vitamines. La carence en vitamines du groupe B, notamment en vitamines Bl, B2 et B6 ainsi que la carence en vitamines C et A engendrent des désordres cutanés qui se manifestent essentiellement par un aspect rugueux de la peau, une absence d'élasticité et un manque d'éclat.It is also known, following numerous scientific studies, that the skin is a tissue particularly sensitive to nutritional deficiencies of vitamins. The deficiency of vitamins of group B, in particular of vitamins B1, B2 and B6 as well as the deficiency of vitamins C and A cause skin disorders which are manifested mainly by a rough appearance of the skin, an absence of elasticity and a lack of 'shine.
En vue de remédier à ces manifestations, il a été proposé des compositions cosmétiques à base de certaines vitamines liposolubles ainsi qu'hydrosolubles dans la mesure où celles-ci étaient suffisamment stables.In order to remedy these manifestations, cosmetic compositions have been proposed based on certain fat-soluble as well as water-soluble vitamins insofar as these were sufficiently stable.
L'acide pantothénique (vitamine B5) a également été proposé comme ayant un effet bénéfique sur la peau, bien qu'il n'y ait pas de preuves certaines d'une pénétration à travers l'épiderme.Pantothenic acid (vitamin B5) has also been proposed to have a beneficial effect on the skin, although there is no definite evidence of penetration through the epidermis.
Ces apports complémentaires de vitamines soit par voie orale, soit par voie topique ne sont généralement pas suffisamment équilibrés en les différentes vitamines de sorte que les traitements à base de compositions polyvitaminiques ne permettent pas d'améliorer l'aspect esthétique de la peau notamment du visage.These additional vitamin intakes, either orally or topically, are generally not sufficiently balanced in the various vitamins so that the treatments based on polyvitamin compositions do not make it possible to improve the aesthetic appearance of the skin, in particular of the face. .
A la suite de nombreuses études réalisées dans ce domaine, on a constaté de façon tout à fait surprenante et inattendue que des résultats particulièrement favorables quant à l'aspect esthétique de la peau, pouvaient être obtenus en combinant simultanément un traitement par voie topique et par voie orale à l'aide de certains mélanges appropriés de vitamines.Following numerous studies carried out in this field, it has been found, quite surprisingly and unexpectedly, that particularly favorable results with regard to the aesthetic appearance of the skin can be obtained by simultaneously combining treatment by topical route and by orally using certain appropriate mixtures of vitamins.
Les résultats obtenus ont en effet permis de mettre en évidence que le traitement selon l'invention améliorait de façon particulièrement 9 •s -2- significative l'aspect de la peau, celle-ci étant plus lisse, plus douce, et plus souple au toucher.The results obtained in fact made it possible to demonstrate that the treatment according to the invention particularly significantly improved the appearance of the skin, the latter being smoother, softer and more supple on to touch.
Par ailleurs, on a constaté que les personnes ainsi traitées avaient dans l'ensemble un visage présentant plus d'éclat et que par ailleurs la peau avait une meilleure résistance aux agressions extérieures.Furthermore, it has been found that the people thus treated generally had a face with more radiance and that, moreover, the skin had better resistance to external aggressions.
La présente invention a donc pour objet une méthode pour améliorer l'aspect esthétique de la peau, celle-ci consistant à appliquer chaque jour sur la peau une composition cosmétique contenant un mélange de vitamines dans un véhicule approprié pour une application topique et à administrer journalierement par voie orale une préparation contenant également un mélange de vitamines dans un véhicule approprié pour une telle administration, ladite méthode étant poursuivie jusqu’à l’amélioration de l'aspect esthétique de la peau,A subject of the present invention is therefore a method for improving the aesthetic appearance of the skin, this method consisting in applying daily to the skin a cosmetic composition containing a mixture of vitamins in a vehicle suitable for topical application and in administering daily by oral route, a preparation also containing a mixture of vitamins in a vehicle suitable for such administration, said method being continued until the aesthetic appearance of the skin is improved,
La mise en oeuvre de la méthode selon l'invention n’implique aucun ordre particulier des deux opérations à la seule condition toutefois que chacune d'elle soit effectuée journalierement durant le traitement.The implementation of the method according to the invention does not imply any particular order of the two operations on the sole condition however that each of them is carried out daily during the treatment.
Des résultats particulièrement appréciables tant à la vue qu’au toucher sont généralement obtenus après une période de trois à cinq semaines.Particularly noticeable results both on sight and on touch are usually obtained after a period of three to five weeks.
Afin de ne pas perdre le bénéfice des effets obtenus, il est particulièrement recommandé de poursuivre le traitement sous forme d'un traitement d’entretien d'une période de 3 à 4 semaines ou moins une fois par an et de préférence 2 à 3 fois par an.In order not to lose the benefit of the effects obtained, it is particularly recommended to continue the treatment in the form of a maintenance treatment for a period of 3 to 4 weeks or less once a year and preferably 2 to 3 times per year.
Le mélange de vitamines de la composition cosmétique administrée par voie topique, est essentiellement constitué de vitamines E, A, B2, B5 et H.The mixture of vitamins of the cosmetic composition administered topically, essentially consists of vitamins E, A, B2, B5 and H.
La vitamine A ou rétinol est présente entre 0,005 et. 0,5% en poids et de préférence entre 0,15 et 0,35%.Vitamin A or retinol is present between 0.005 and. 0.5% by weight and preferably between 0.15 and 0.35%.
La vitamine E ou ^-tocophérol, de préférence sous forme d'acétate d*£^ -tocophérol, est généralement présente entre 0,3 et 4% en poids et de préférence entre 1,5 et 3%.Vitamin E or ^ -tocopherol, preferably in the form of acetate of ^ -tocopherol, is generally present between 0.3 and 4% by weight and preferably between 1.5 and 3%.
La vitamine B2 ou riboflavine, sous forme de son sel de sodium du dérivé 5* phosphate, est présente entre 0,001 et 0,01% et de préférence entre 0,002 et 0,008%.Vitamin B2 or riboflavin, in the form of its sodium salt of the 5 * phosphate derivative, is present between 0.001 and 0.01% and preferably between 0.002 and 0.008%.
La vitamine B5 ou acide pantothénique, de préférence sous forme de D-pantothênate de calcium ou de sodium, est présente entre 0,5 et 3% et de préférence entre 1 et 2%.Vitamin B5 or pantothenic acid, preferably in the form of calcium or sodium D-pantothenate, is present between 0.5 and 3% and preferably between 1 and 2%.
La vitamine H ou biotine est présente entre 0,01 et 0,05% et de préférence entre 0,015 et 0,03%.Vitamin H or biotin is present between 0.01 and 0.05% and preferably between 0.015 and 0.03%.
Ces différents pourcentages sont ici exprimés par rapport au poids total de la composition cosmétique.These different percentages are here expressed relative to the total weight of the cosmetic composition.
X.X.
-3- r I 1-3- r I 1
Les études qui ont été réalisées ont permis de mettre en évidence l'importance de ces différentes vitamines en vue de l'effet cosmétique recherché.The studies that have been carried out have made it possible to highlight the importance of these various vitamins with a view to the desired cosmetic effect.
La composition cosmétique peut se présenter sous diverses formes permettant une application commode de la composition sur la peau notamment sur le visage.The cosmetic composition can be in various forms allowing convenient application of the composition to the skin, in particular to the face.
Ainsi celle-ci peut être par exemple une crème, un lait ou encore une émulsion du type huile-dans-l'eau ou eau-dans-1'huile.Thus this can be for example a cream, a milk or an emulsion of the oil-in-water or water-in-1 oil type.
Il convient bien entendu que le véhicule de la composition n'ait aucune incidence néfaste sur la stabilité du mélange des vitamines.It should be understood that the vehicle of the composition has no harmful effect on the stability of the mixture of vitamins.
Les agents émulsionnants de ces compositions sont généralement compris entre 1 et 20% et de préférence entre 2 et 12% en poids par rapport au poids total de la composition.The emulsifiers of these compositions are generally between 1 and 20% and preferably between 2 and 12% by weight relative to the total weight of the composition.
Parmi les différents agents émulsionnants qui peuvent être utilisés, on peut en particulier citer : - les esters d'acides gras polyoxyéthylénés ou polyglycérolés, - les alcools gras oxyéthylénés ou polyglycérolés comme par exemple l'alcool oléique polyoxyéthyléné à 10 moles d'oxyde d'éthylène, l'alcool stéarylique polyoxyéthyléné de 10 à 20 moles d'oxyde d'éthylène, l'alcool oléique polyglycérolé à 4 moles de glycérol et les alcools gras synthétiques en C-C. polyoxyéthylénés de 5 à 10 moles d'oxyde y 15 d'éthylène, - les sulfates d'alkyle oxyéthylénés ou non, comme le lauryl sulfate de sodium, le lauryl sulfate d'ammonium, le cétyl stéaryl sulfate de sodium, le cétyl stéaryl sulfate de triéthanolamine, le lauryl sulfate de monoéthanolamine, le lauryl éther sulfate de sodium oxyéthyléné (à 2,2 moles d'oxyde d'éthylène par exemple) et le lauryl éther sulfate de monoéthanolamine oxyéthyléné (à 2,2 moles d'oxyde d'éthylène par exemple), et des savons tels que le stéarate de triéthanolamine.Among the various emulsifying agents which can be used, mention may in particular be made of: ethylene, polyoxyethylenated stearyl alcohol from 10 to 20 moles of ethylene oxide, polyglycerolated oleic alcohol to 4 moles of glycerol and synthetic fatty alcohols in CC. polyoxyethylenated from 5 to 10 moles of ethylene oxide and 15, alkyl sulphates oxyethylenated or not, such as sodium lauryl sulfate, ammonium lauryl sulfate, sodium cetyl stearyl sulfate, cetyl stearyl sulfate of triethanolamine, monoethanolamine lauryl sulfate, oxyethylenated sodium lauryl ether sulfate (with 2.2 moles of ethylene oxide for example) and oxyethylenated monoethanolamine lauryl ether sulfate (with 2.2 moles of oxide of ethylene for example), and soaps such as triethanolamine stearate.
On peut également mentionner le système émulsionnant constitué de lanolate de magnésium et d'alcool de lanoline et/ou de lanoline hydrogénée.One can also mention the emulsifying system consisting of magnesium lanolate and lanolin alcohol and / or hydrogenated lanolin.
La phase eau des émulsions peut éventuellement contenir des agents gélifiants tels que par exemple l'hydroxy propyl méthylcellulose. La phase huile constituée d'au moins une huile et éventuellement d'au moins une cire, varie entre environ 8 et 50% en poids par rapport au poids total de la composition.The water phase of the emulsions may optionally contain gelling agents such as, for example, hydroxypropyl methylcellulose. The oil phase consisting of at least one oil and optionally at least one wax varies between approximately 8 and 50% by weight relative to the total weight of the composition.
Parmi les produits gras constituant la phase grasse de ces compositions, on peut citer : -4- r - les huiles hydrocarbonées comme l’huile de paraffine, l’huile de purcellin, le perhydrosqualène et les solutions de cires microcristallines dans les huiles, - les huiles animales ou végétales comme l'huile d’amande douce, l'huile d'avocat, l'huile de calophyllum, la lanoline, l'huile de ricin, l'huile de cheval, l'huile de porc, l’huile de sésame, l'huile d'olive, l'huile de jojoba, l'huile de karité, l'huile d’hoplostéthus, l'huile de tournesol, - les huiles minérales dont le point initial de distillation à pression atmosphérique est d'environ 250°C et le point final de l'ordre de 410°C, - les esters saturés ou non tels que les myristates d'alkyle comme ceux d'isopropyle, de butyle ou de cétyle, le stéarate d'héxadécyle, les palmitates d’éthyle ou d'isopropyle, les triglycérides des acides octanoîque et décanoïque et le ricinoléate de cétyle.Among the fatty products constituting the fatty phase of these compositions, there may be mentioned: -4- r - hydrocarbon oils such as paraffin oil, purcellin oil, perhydrosqualene and solutions of microcrystalline waxes in oils, - animal or vegetable oils such as sweet almond oil, avocado oil, calophyllum oil, lanolin, castor oil, horse oil, pork oil, sesame oil, olive oil, jojoba oil, shea oil, hoplostethus oil, sunflower oil, - mineral oils whose initial point of distillation at atmospheric pressure is about 250 ° C and the end point of the order of 410 ° C, - saturated or unsaturated esters such as alkyl myristates such as those of isopropyl, butyl or cetyl, hexadecyl stearate, ethyl or isopropyl palmitates, triglycerides of octanoic and decanoic acids and cetyl ricinoleate.
La composition cosmétique peut également contenir d'autres vitamines que celles énumérées, notamment de la vitamine F (Acides gras essentiels), de la vitamine D, de la vitamine B6, ou encore l'acide folique ainsi que d'autres substances pour l'entretien et l'amélioration des propriétés de la peau telles que par exemple des humectants, des agents revitalisants et des dérivés protéiniques.The cosmetic composition may also contain vitamins other than those listed, in particular vitamin F (essential fatty acids), vitamin D, vitamin B6, or even folic acid as well as other substances for the maintenance and improvement of the properties of the skin such as for example humectants, revitalizing agents and protein derivatives.
Selon une forme de réalisation particulière, la composition cosmétique contient entre 0,005 et 0,025% d'acide folique et de préférence entre 0,0075 et 0,015%.According to a particular embodiment, the cosmetic composition contains between 0.005 and 0.025% of folic acid and preferably between 0.0075 and 0.015%.
Certaines vitamines, notamment hydrosolubles, peuvent être incorporées dans des micro-dispersions du type liposomes.Certain vitamins, in particular water-soluble vitamins, can be incorporated into micro-dispersions of the liposome type.
Par ailleurs, la composition peut également contenir des colorants, des parfums, des filtres solaires, des anti-oxydants ainsi que des conservateurs tels que le parahydroxybenzoate de méthyle ou le parahydroxybenzoate de propyle.Furthermore, the composition may also contain dyes, perfumes, sunscreens, antioxidants as well as preservatives such as methyl parahydroxybenzoate or propyl parahydroxybenzoate.
Il est préférable d’appliquer la composition cosmétique en effectuant un léger massage afin de la bien faire pénétrer, cette application étant de préférence réalisée le soir de façon à bien laisser agir et pénétrer la composition pendant la nuit.It is preferable to apply the cosmetic composition by carrying out a light massage in order to make it penetrate well, this application being preferably carried out in the evening so as to leave it to act well and to penetrate the composition during the night.
Les compositions cosmétiques suivantes se sont montrées particulièrement favorables dans la méthode pour améliorer l'aspect esthétique de la peau selon l'invention: r -5- l 1) Crème du type eau-dans-lThuile Mélanges de vitamines:The following cosmetic compositions have been shown to be particularly favorable in the method for improving the aesthetic appearance of the skin according to the invention: r -5- l 1) Cream of the water-in-oil type Vitamin mixtures:
Vitamine E.............. 1,5%Vitamin E .............. 1.5%
Vitamine A................................... 0,3%Vitamin A ................................... 0.3%
Vitamine B2.................................. 0,003%Vitamin B2 .................................. 0.003%
Vitamine B5.................................. 1%Vitamin B5 .................................. 1%
Vitamine H................................... 0,02%Vitamin H ................................... 0.02%
Vitamine F................................... 2%Vitamin F ................................... 2%
Acide folique................................ 0,008%Folic acid ................................ 0.008%
Lanolate de magnésium............................. 7%Magnesium lanolate ............................. 7%
Alcool de lanoline................................ 3%Lanolin alcohol ................................ 3%
Myristate d’isopropyle............................ 8%Isopropyl myristate ............................ 8%
Huile de tournesol................................ 30%Sunflower oil ................................ 30%
Vaseline.................. 10%Vaseline .................. 10%
Parahydroxybenzoate de méthyle.................... 0,2%Methyl parahydroxybenzoate .................... 0.2%
Parahydroxybenzoate de propyle.................... 0,1%Propyl parahydroxybenzoate .................... 0.1%
Eau q.s.p......................................... 100% * 2) Emulsion du type huile-dans-l’eau Mélanges de vitamines.Water qs ........................................ 100% * 2) Emulsion of the type oil-in-water Mixtures of vitamins.
Vitamine E................................... 3%Vitamin E ................................... 3%
Vitamine A................................... 0,2%Vitamin A ................................... 0.2%
Vitamine B2.................................. 0,007%Vitamin B2 .................................. 0.007%
Vitamine B5.................................. 2%Vitamin B5 .................................. 2%
Vitamine H................................... 0,03%Vitamin H ................................... 0.03%
Acide folique,............................... 0,015%Folic acid, ............................... 0.015%
Perhydrosqualène.................................. 10%Perhydrosqualene .................................. 10%
Polyéthylèneglycol 400............................ 3%Polyethylene glycol 400 ............................ 3%
Propylèneglycol................................... 4%Propylene glycol ................................... 4%
Triéthanolamine................................... 0,6%Triethanolamine ................................... 0.6%
Huile d’amande douce.............................. 2%Sweet almond oil .............................. 2%
Myristate d'isopropyle............................ 1%Isopropyl myristate ............................ 1%
Esters d’acides caprique et caprylique et d’alcool gras en C10-C10....................... 1% le ioEsters of capric and caprylic acids and fatty alcohol C10-C10 ....................... 1% per io
Alcool cétylique.................................. 0,5%Cetyl alcohol .................................. 0.5%
Acide stéarique................................... 3% -6- w lStearic acid ................................... 3% -6- w l
Mono- et di-stéarate de glycérol non auto- émulsionnables.................................... 3%Non-self-emulsifiable glycerol mono- and di-stearate .................................... 3%
Parfum............................................ 0,1%Perfume ............................................ 0.1%
Conservateurs..................................... 0,2%Preservatives ..................................... 0.2%
Eau q.s.p............................... 100% 3) Lait du type h.uile-dans-lt eau Mélanges de vitamines.Water qs .............................. 100% 3) Oil-in-lt water type milk Vitamin mixtures .
Vitamine E................................... 2%Vitamin E ................................... 2%
Vitamine A................................... 0,15%Vitamin A ................................... 0.15%
Vitamine B2............. 0,002%Vitamin B2 ............. 0.002%
Vitamine B5.................................. 2%Vitamin B5 .................................. 2%
Vitamine H................................... 0,015%Vitamin H ................................... 0.015%
Huile de karité................................... 3%Shea oil ................................... 3%
Huile de vaseline................................. 8%Vaseline oil ................................. 8%
Stéarate de glycérol.............................. 2%Glycerol stearate .............................. 2%
Monostéarate de sorbitan oxyéthyléné à 20 moles d’oxyde d’éthylène (Tween 60)..................... 1%Sorbitan monostearate oxyethylenated with 20 moles of ethylene oxide (Tween 60) ..................... 1%
Acide stéarique................................... 1,4%Stearic acid ................................... 1.4%
Trié thano lamine................................... 0,7%Sorted thano laminate ................................... 0.7%
Carbopol 940 (neutralisé)......................... 0,2%Carbopol 940 (neutralized) ......................... 0.2%
Butylhydroxyanisol/butylhydroxytoluène (50/50)...... 0,1%Butylhydroxyanisol / butylhydroxytoluene (50/50) ...... 0.1%
Parfum............................................ 1%Perfume ............................................ 1%
Eau + conservateurs q.s.p....................... 100% 4) Lait du type huile-dans-1’eauWater + preservatives q.s.p ....................... 100% 4) Milk of the oil-in-1 type water
Vitamine E...,.............................. 2,50%Vitamin E ..., .............................. 2.50%
Vitamine A............................... 0,35%Vitamin A ............................... 0.35%
Vitamine B2........................ 0,008%Vitamin B2 ........................ 0.008%
Vitamine B5................................. 1,50%Vitamin B5 ................................. 1.50%
Vitamine H.................................. 0,02%Vitamin H .................................. 0.02%
Sesquioléate· de sorbitan...................... 2,00%Sorbitan sesquioleate ...................... 2.00%
Stéarate de glycérol oxyéthyléné à 20 moles d’oxyde d’éthylène........ 2,00%Oxyethylenated glycerol stearate with 20 moles of ethylene oxide ........ 2.00%
Alcool cétylique................................. 1,00%Cetyl alcohol ................................. 1.00%
Huile de vaseline............................ 10,00% τ -7- rVaseline oil ............................ 10.00% τ -7- r
Huile de jojoba............. 2,00%Jojoba oil ............. 2.00%
Carbopol 940..................................... 0,20%Carbopol 940 ..................................... 0.20%
Triéthanolamine.................................. 0,20%Triethanolamine .................................. 0.20%
Parfum........................... 1,00%Perfume ........................... 1.00%
Parahydroxybenzoate de méthyle................... 0,30%Methyl parahydroxybenzoate ................... 0.30%
Eau déminéralisée stérile q.s.p.................. 100%Sterile demineralized water q.s.p .................. 100%
La préparation polyvitaminée qui est administrée par voie orale selon la méthode de 1'invention, est essentiellement constituée d'un mélange des vitamines E, A, B2, B5, H, B1 et C.The polyvitamin preparation which is administered orally according to the method of the invention, essentially consists of a mixture of vitamins E, A, B2, B5, H, B1 and C.
Comme on peut le constater, la préparation par voie orale et la composition cosmétique se caractérisent essentiellement par la présence de certaines mêmes vitamines â savoir les vitamines A, E, B2, B5 et H.As can be seen, the oral preparation and the cosmetic composition are essentially characterized by the presence of certain same vitamins, namely vitamins A, E, B2, B5 and H.
La vitamine A est de préférence administrée par voie orale sous forme de Provitamine A -carotène).Vitamin A is preferably administered orally in the form of Provitamin A -carotene).
La vitamine B1 ou thiamine est de préférence administrée sous sa forme de chlorhydrate ou de nitrate et la vitamine C ou acide L-ascorbique sous forme de ses sels de calcium ou de sodium ou encore sous forme de palmitate d'ascorbyle.Vitamin B1 or thiamine is preferably administered in its hydrochloride or nitrate form and vitamin C or L-ascorbic acid in the form of its calcium or sodium salts or also in the form of ascorbyl palmitate.
Les doses journalières de ces vitamines devant être administrées selon la méthode de l'invention, en une ou plusieurs prises, sont les suivantes :The daily doses of these vitamins to be administered according to the method of the invention, in one or more doses, are as follows:
Provitamine A -carotène).................. 1,2 à 7,2mgProvitamin A -carotene) .................. 1.2 to 7.2mg
Vitamine E.................................. 3,75 à 22,5mgVitamin E .................................. 3.75 to 22.5mg
Vitamine B2.................................. 0,3 à 2,5mgVitamin B2 .................................. 0.3 to 2.5mg
Vitamine B5.................................. 2,5 à 15mgVitamin B5 .................................. 2.5 to 15mg
Vitamine H................................... 0,075 à 0,45mgVitamin H ................................... 0.075 to 0.45 mg
Vitamine B1.................................. 0,3 à 2mgVitamin B1 .................................. 0.3 to 2mg
Vitamine C................................... 20 à 120mgVitamin C ................................... 20 to 120mg
La préparation par voie orale peut également contenir d'autres vitamines notamment de la vitamine PP, de la vitamine B6 (chlorhydrate de pyridoxine), ainsi que certains éléments minéraux et oligoéléments tels que par exemple du glycérophosphate de magnésium, du citrate de magnésium, du gluconate de magnésium, du phosphate ferreux, du citrate cuivrique, du gluconate cuivrique, de l'acétate de zinc, du gluconate de zinc, du chlorure de zinc, des sels de sélénite ainsi que de la séléniométhionine.The oral preparation may also contain other vitamins, in particular vitamin PP, vitamin B6 (pyridoxine hydrochloride), as well as certain mineral elements and trace elements such as for example magnesium glycerophosphate, magnesium citrate, magnesium gluconate, ferrous phosphate, cupric citrate, cupric gluconate, zinc acetate, zinc gluconate, zinc chloride, selenite salts as well as seleniomethionine.
Ces compositions par voie orale peuvent se présenter sous différentes formes notamment sous forme de comprimés, d'une poudre, de granulés, de pilules, de capsules, de gélules ou encore sous forme d'un sirop, d’une suspension, ou d'une solution.These oral compositions can be in various forms, in particular in the form of tablets, a powder, granules, pills, capsules, capsules or also in the form of a syrup, a suspension, or a solution.
r -8-r -8-
Parmi ces différentes formes, celles particulièrement préférées, selon la méthode de l’invention, sont les capsules et les gélules.Among these different forms, those which are particularly preferred, according to the method of the invention, are capsules and capsules.
Selon une forme de réalisation préférée, le mélange de vitamines est associé à au moins une huile végétale alimentaire telle que par exemple l'huile de carthame, l’huile de germes de blé, l’huile d'onagre, l'huile de bourrache, l’huile de pépins de cassis, l’huile d'arachide, l'huile de soja ou à une huile animale d’origine marine riche en acides gras polyinsaturés.According to a preferred embodiment, the mixture of vitamins is associated with at least one edible vegetable oil such as for example safflower oil, wheat germ oil, evening primrose oil, borage oil , blackcurrant seed oil, peanut oil, soybean oil or an animal oil of marine origin rich in polyunsaturated fatty acids.
Ces huiles sont particulièrement recommandées dans la mesure où elles apportent de l’acide linoléique ainsi que de l’acide % -linolénique (Acides gras essentiels).These oils are particularly recommended since they provide linoleic acid as well as% -linolenic acid (essential fatty acids).
La préparation par voie orale peut également contenir divers ingrédients conventionnels tels que par exemple des charges, des produits édulcorants, etc...The oral preparation can also contain various conventional ingredients such as, for example, fillers, sweeteners, etc.
Les préparations suivantes se sont montrées particulièrement appropriées dans la méthode pour améliorer l’aspect esthétique de la peau selon l'invention: A - Capsule molle de gélatine de 462 mg Composition par capsule:The following preparations have been shown to be particularly suitable in the method for improving the aesthetic appearance of the skin according to the invention: A - Soft gelatin capsule of 462 mg Composition per capsule:
Huile d'arachide............................. 103mgPeanut oil ............................. 103mg
Huile de soja hydrogénée..................... 15,0mgHydrogenated soybean oil ..................... 15.0mg
Huile de carthame............................ 85mg ^ -carotène à 20% en suspension huileuse..... 3,45mg (0,69mg dej^ -carotène)Safflower oil ............................ 85mg ^ -carotene 20% in oily suspension ..... 3.45mg ( 0.69 mg of carotene)
Vitamine E................................... 7,5mgVitamin E ................................... 7.5mg
Vitamine B1.................................. 0,780mgVitamin B1 .................................. 0.780mg
Vitamine B2........................ 0,863mgVitamin B2 ........................ 0.863 mg
Vitamine B5.................................. 5,0mgVitamin B5 .................................. 5.0mg
Vitamine H................................... 0,150mgVitamin H ................................... 0.150mg
Vitamine C (acide ascorbique)................. 25,0mgVitamin C (ascorbic acid) ................. 25.0mg
Levure........................................ 70,0mgYeast ........................................ 70,0mg
Afin d’avoir les doses requises en vitamines on administre deux capsules de 462mg par jour.In order to have the required doses of vitamins, two capsules of 462 mg per day are administered.
B - Capsule molle de gélatine de 463mg Composition par capsule:B - Soft gelatin capsule of 463mg Composition per capsule:
Huile de germes de blé....................... I68mgWheat germ oil ....................... I68mg
Vitamine E................................... 15,75mg 3 -carotène à 20% en suspension huileuse..... 13,8mg (2,76mg dej^> -carotène)Vitamin E ................................... 15.75mg 3 -carotene 20% in oily suspension. .... 13.8 mg (2.76 mg dej ^> -carotene)
Vitamine B1.................................. 0,690mg r -9-Vitamin B1 .................................. 0.690mg r -9-
Vitamine B2.................................. 0,660mgVitamin B2 .................................. 0.660mg
Vitamine B5...........,...................... 10mgVitamin B5 ..........., ...................... 10mg
Vitamine H................................... 0,150mgVitamin H ................................... 0.150mg
Vitamine C (acide ascorbique)................ 50mgVitamin C (ascorbic acid) ................ 50mg
Acide folique................................ 0,230mgFolic acid ................................ 0.230mg
Vitamine B6.................................. 1, ImgVitamin B6 .................................. 1, Img
Vitamine PP.................................. 7,5mg Sélénium (levure sélénium à 1000mcg/g)....... 40mg (40mcg sélénium) L'administration d'une capsule de 463mg par jour apporte les doses requises de vitamines.Vitamin PP .................................. 7.5mg Selenium (selenium yeast at 1000mcg / g) .. ..... 40mg (40mcg selenium) The administration of a capsule of 463mg per day provides the required doses of vitamins.
C - Suspension ^ -carotène à 20% en suspension huileuse.... Ij25g (0,25g deg -carotène)C - Suspension ^ -carotene at 20% in oily suspension .... Ij25g (0.25g deg -carotene)
Vitamine Bl,................................. 0,065gVitamin Bl, ................................. 0.065g
Vitamine B2.................................. 0,105gVitamin B2 .................................. 0.105g
Vitamine B5.................................. 0,55gVitamin B5 .................................. 0.55g
Vitamine C................................... 2,5gVitamin C ................................... 2.5g
Vitamine E................................... IgVitamin E ................................... Ig
Vitamine H................................... 0,005gVitamin H ................................... 0.005g
Huile de pépins de cassis q.s.p.............. 100ml L’administration de 2ml de la suspension par jour apporte les doses requises de vitamines.Blackcurrant seed oil q.s.p .............. 100ml The administration of 2ml of the suspension per day provides the required doses of vitamins.
Bien que la méthode pour améliorer l'aspect esthétique de la peau ait été décrite en se référant à certaines formes préférées de mise en oeuvre, il va de soi qu'elle peut être réalisée à l'aide d'autres formes de réalisation sans pour autant sortir ni de son cadre, ni de son objet.Although the method for improving the aesthetic appearance of the skin has been described with reference to certain preferred embodiments, it goes without saying that it can be carried out using other embodiments without as much to leave neither its framework, nor its object.
La présente invention a également pour objet un coffret , pour la mise en oeuvre de la méthode selon l'invention, celui-ci étant constitué de deux parties, la première partie étant constituée par la composition cosmétique et la deuxième partie par la préparation par voie orale, chaque partie étant présente en des quantités permettant la mise en oeuvre de la m méthode pendant au moins 15 jours.The present invention also relates to a box, for the implementation of the method according to the invention, this consisting of two parts, the first part being constituted by the cosmetic composition and the second part by the preparation by oral, each part being present in quantities allowing the implementation of the m method for at least 15 days.
Claims (12)
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU87145A LU87145A1 (en) | 1988-02-26 | 1988-02-26 | METHOD FOR IMPROVING THE AESTHETIC APPEARANCE OF THE SKIN USING POLYVITAMIN MIXTURES |
| JP1045032A JPH01268617A (en) | 1988-02-26 | 1989-02-23 | Skin beauty improving cosmetics composed of polyvitamin mixture |
| DE89400531T DE68908437T2 (en) | 1988-02-26 | 1989-02-24 | Process for improving the aesthetic appearance of the skin with the help of polyvitamin mixtures and cosmetic compositions for its implementation. |
| EP89400531A EP0330583B1 (en) | 1988-02-26 | 1989-02-24 | Method for enhancing the esthetic aspect of the skin with the aid of polyvitaminised mixtures, and cosmetic compositions for its application |
| ES92119446T ES2086617T3 (en) | 1988-02-26 | 1989-02-24 | DERMATOLOGICAL COSMETIC COMPOSITION BASED ON POLYVITAMIN MIXTURES. |
| EP92119446A EP0530862B1 (en) | 1988-02-26 | 1989-02-24 | Dermatological cosmetic composition containing polyvitamined mixtures |
| DE68926250T DE68926250T2 (en) | 1988-02-26 | 1989-02-24 | Dermatological cosmetic composition containing polyvitamin blends |
| AU30756/89A AU612004B2 (en) | 1988-02-26 | 1989-02-24 | Cosmetic composition for improving the aesthetic appearance of the skin based on multivitamin mixtures |
| AT92119446T ATE136455T1 (en) | 1988-02-26 | 1989-02-24 | DERMATOLOGICAL COSMETIC COMPOSITIONS CONTAINING POLYVITAMIN MIXTURES |
| AT89400531T ATE93135T1 (en) | 1988-02-26 | 1989-02-24 | METHOD OF IMPROVING THE AESTHETIC APPEARANCE OF THE SKIN WITH THE MEANS OF POLYVITAMIN MIXTURES AND COSMETIC COMPOSITIONS FOR ITS PERFORMANCE. |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU87145A LU87145A1 (en) | 1988-02-26 | 1988-02-26 | METHOD FOR IMPROVING THE AESTHETIC APPEARANCE OF THE SKIN USING POLYVITAMIN MIXTURES |
| LU87145 | 1988-02-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU87145A1 true LU87145A1 (en) | 1989-09-20 |
Family
ID=19731029
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU87145A LU87145A1 (en) | 1988-02-26 | 1988-02-26 | METHOD FOR IMPROVING THE AESTHETIC APPEARANCE OF THE SKIN USING POLYVITAMIN MIXTURES |
Country Status (7)
| Country | Link |
|---|---|
| EP (2) | EP0530862B1 (en) |
| JP (1) | JPH01268617A (en) |
| AT (2) | ATE136455T1 (en) |
| AU (1) | AU612004B2 (en) |
| DE (2) | DE68908437T2 (en) |
| ES (1) | ES2086617T3 (en) |
| LU (1) | LU87145A1 (en) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9006785D0 (en) * | 1990-03-27 | 1990-05-23 | Leung Lit Hung | Composition and methods for treatment of acne vulgaris and retardation of ageing |
| DE4018964C1 (en) * | 1990-06-13 | 1991-07-04 | Gerhard Prof. Dr.Med. 8602 Muehlhausen De Weber | |
| SE468541B (en) * | 1990-07-17 | 1993-02-08 | Maja Zeidler | CONCENTRATED MIXTURE CONTAINING VITAMINES FOR ADDITION TO SKIN FOOD |
| JPH0491769A (en) * | 1990-08-08 | 1992-03-25 | World Foods Kk | Preparation of beta-carotene beverage |
| JP3545429B2 (en) * | 1992-07-13 | 2004-07-21 | 株式会社資生堂 | Retinol stable combination skin external preparation |
| FR2694692B1 (en) * | 1992-08-13 | 1994-10-28 | Thorel Jean Noel | Cosmetic preparation for skin nutrition. |
| DE4232140C2 (en) * | 1992-09-25 | 1995-12-14 | Medi Concept Unternehmensberat | Care set for the treatment of skin in neurodermatitis |
| FR2697750B1 (en) * | 1992-11-06 | 1995-01-20 | Lucien Eustatiu | Cosmetic preparations revitalizing the skin. |
| US5520991A (en) * | 1992-11-06 | 1996-05-28 | Eustatiu; Lucien | Cosmetic preparations for revitalizing the skin |
| FR2698268B1 (en) * | 1992-11-24 | 1995-01-20 | Oreal | Photoprotective composition administered orally. |
| DE4242876C2 (en) * | 1992-12-18 | 1997-11-27 | Beiersdorf Ag | Cosmetic and / or dermatological preparations for the cosmetic and / or dermatological care of the skin and / or the skin appendages |
| FR2714595B1 (en) * | 1993-12-30 | 1996-02-02 | Oreal | Water in oil emulsion containing retinol, its use and packaging. |
| FR2718353B3 (en) * | 1994-04-11 | 1996-06-28 | Jean Berque | Pharmaceutical compositions based on non-toxic biological products intended for the local protection of the genital and rectal mucosa. |
| FR2722094B1 (en) * | 1994-07-05 | 1997-07-11 | Jcb Cosmetiques | ORAL COMPOSITION FOR REACTIVATING THE FLAG TANNING BASED ON A CAROTENOID AND A TOCOPHEROL |
| UA10208A (en) * | 1994-08-03 | 1996-12-25 | Жанна Прокопівна Гудзенко | Dermatological cosmetic preparation |
| US6149610A (en) * | 1996-07-02 | 2000-11-21 | Urko; Marina Sergeevna | Method for massaging the neck and the face and device for realising the same |
| DE19701651A1 (en) * | 1997-01-18 | 1998-07-23 | Rovi Gmbh Handelsgesellschaft | Aqueous composition with liposomes containing biotin |
| IT1306141B1 (en) * | 1999-05-17 | 2001-05-30 | Giampiero Valletta | COMPOSITION FOR THE TREATMENT OF UREMIC ITCHING AND OF DEPRURED FORMS NOT RELATED TO ORGANIC INJURIES. |
| GB9918025D0 (en) * | 1999-07-30 | 1999-09-29 | Unilever Plc | Skin care composition |
| GB9919079D0 (en) * | 1999-08-12 | 1999-10-13 | Clayton Paul R | Skin care product |
| EP1275369A1 (en) * | 2001-07-10 | 2003-01-15 | Goldschmidt AG | Folic acid containing personal care product |
| CN1816287A (en) * | 2003-01-31 | 2006-08-09 | 宝洁公司 | Means for improving the appearance of mammalian keratinous tissue |
| BR0318343A (en) * | 2003-05-16 | 2006-07-11 | Lotus Pharmaceutical Co Ltd | topical composition for transdermal administration |
| JP2005041861A (en) * | 2003-07-09 | 2005-02-17 | Takeda Chem Ind Ltd | Inhibitor for reducing water content in horny layer of skin |
| FR2886154B1 (en) * | 2005-05-27 | 2010-03-26 | Cothera | COMPOSITION FOR DELAYING THE DEVELOPMENT OF ALZHEIMER'S DISEASE |
| CN1911238A (en) * | 2005-08-08 | 2007-02-14 | 美时化学制药股份有限公司 | Compositions for skin and methods of use thereof |
| DE102006038758A1 (en) * | 2006-04-25 | 2007-10-31 | Christine Schrammek Kosmetik Gmbh & Co. Kg | Use of a skin cream and dietary supplements |
| FR2996136B1 (en) * | 2012-09-28 | 2015-01-02 | Inneov Lab | USE OF AN ASSOCIATION OF AT LEAST ONE POLYUNSATURATED FATTY ACID AND AT LEAST ONE CAROTENOID TO ENHANCE THE QUALITY OF NAILS. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2312086C3 (en) * | 1972-03-30 | 1979-10-31 | N.V. Philips' Gloeilampenfabrieken, Eindhoven (Niederlande) | Signal transmission device with an amplitude and frequency dependent transmission function |
| GB1431841A (en) * | 1973-01-15 | 1976-04-14 | Evans S C | Ophthalmic-nutritional preparations |
| EP0071598B1 (en) * | 1981-02-17 | 1990-05-09 | BAZZANO, Gail S | The use of retinoids and their derivatives to increase the rate of growth of human scalp hair and to increase the rate of growth of fur in certain furbearing animals |
| AU4805085A (en) * | 1984-09-05 | 1986-03-24 | Schering Aktiengesellschaft | Mittel zur behandlung von androgenisierungserscheinungen und verwendung von antiandrogenen zur herstellung des mittels |
| AU587863B2 (en) * | 1985-10-07 | 1989-08-31 | Basf Aktiengesellschaft | Vitamin-containing granules and production thereof |
| GB2212722B (en) * | 1987-11-25 | 1991-12-11 | Theravit Limited | Vitamin compositions |
-
1988
- 1988-02-26 LU LU87145A patent/LU87145A1/en unknown
-
1989
- 1989-02-23 JP JP1045032A patent/JPH01268617A/en active Pending
- 1989-02-24 AT AT92119446T patent/ATE136455T1/en not_active IP Right Cessation
- 1989-02-24 EP EP92119446A patent/EP0530862B1/en not_active Expired - Lifetime
- 1989-02-24 DE DE89400531T patent/DE68908437T2/en not_active Expired - Fee Related
- 1989-02-24 AU AU30756/89A patent/AU612004B2/en not_active Ceased
- 1989-02-24 AT AT89400531T patent/ATE93135T1/en not_active IP Right Cessation
- 1989-02-24 ES ES92119446T patent/ES2086617T3/en not_active Expired - Lifetime
- 1989-02-24 EP EP89400531A patent/EP0330583B1/en not_active Expired - Lifetime
- 1989-02-24 DE DE68926250T patent/DE68926250T2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0530862A3 (en) | 1993-11-10 |
| ATE93135T1 (en) | 1993-09-15 |
| DE68908437T2 (en) | 1994-02-03 |
| DE68926250T2 (en) | 1996-11-21 |
| EP0330583A3 (en) | 1991-03-13 |
| EP0530862B1 (en) | 1996-04-10 |
| DE68926250D1 (en) | 1996-05-15 |
| EP0330583B1 (en) | 1993-08-18 |
| ES2086617T3 (en) | 1996-07-01 |
| AU612004B2 (en) | 1991-06-27 |
| JPH01268617A (en) | 1989-10-26 |
| DE68908437D1 (en) | 1993-09-23 |
| EP0530862A2 (en) | 1993-03-10 |
| AU3075689A (en) | 1989-08-31 |
| EP0330583A2 (en) | 1989-08-30 |
| ATE136455T1 (en) | 1996-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0330583B1 (en) | Method for enhancing the esthetic aspect of the skin with the aid of polyvitaminised mixtures, and cosmetic compositions for its application | |
| JP2969179B2 (en) | Synthetic preparations to promote hair growth and, optionally, skin and nail growth, to prevent or control hair loss | |
| CA2312528C (en) | Cosmetic toning compound containing at least one hydroxystilbene in association with ascorbic acid | |
| EP0862910B1 (en) | Use of retinoids as skin pigmentation inducing agent | |
| EP1872772B1 (en) | Use of biotin or a biotin derivative for lightening skin and/or for smoothening skin color irregularities | |
| CA2695235C (en) | Use of hesperidin or of a derivative thereof for the prevention and/or treatment of slackened skin | |
| FR2751537A1 (en) | USE OF HONEY AS A KERATOLYTIC AGENT, IN PARTICULAR FOR IMPROVING SKIN DYE SKIN AND TREATING WRINKLES | |
| FR2777186A1 (en) | Compositions for stimulating collagen synthesis and/or skin fibroblast proliferation, especially for cosmetic use | |
| FR2998477A1 (en) | TWO-COMPONENT SYSTEMS FOR ADMINISTERING STABILIZED ASCORBIC ACID | |
| CA2306414A1 (en) | Compositions based on plant extracts | |
| CA2136706C (en) | Process for controlling adiposity and compositions for use therein | |
| EP0938891A1 (en) | Cosmetic composition containing cinnamic acid or its derivatives and its use | |
| EP1172080B1 (en) | Use of a composition comprising vitamins and mineral salts to reduce the hairloss and/or to promote the hairregrowth | |
| EP1252882A1 (en) | Process to increase the threshold tolerance of the sensitive skin | |
| FR2722985A1 (en) | NOVEL COMPOSITIONS BASED ON A SYNERGETIC MIXTURE BETWEEN AT LEAST ONE LIGAND SPECIFIC FOR RXRS AND AT LEAST ONE LIGAND SPECIFIC FOR RAR-X OR VDR, AND USES THEREOF | |
| WO2006021660A1 (en) | Use of at least one conjugated triene-containing fatty acid for preparing a medicine for treating inflammation | |
| EP0490749A1 (en) | Two-phase liquid cosmetic cleansing composition containing at least a dialkylphthalate and an anionic, amphoteric, or zwitterionic surface active agent | |
| CH666620A5 (en) | DRUG COMPOSITION FOR THE TREATMENT OR PREVENTION OF ACNE BY TOPICAL APPLICATION. | |
| AU2006239555B8 (en) | Hair tonic | |
| JPH11510824A (en) | Cosmetic method for treatment and prevention of signs of skin aging | |
| JPH08291025A (en) | Hair tonic | |
| JPH11322628A (en) | External preparation for skin | |
| EP0697206A1 (en) | Cosmetic or pharmaceutical microemulsion and uses thereof | |
| WO2006000708A1 (en) | Composition comprising a blue lotus extract having a relaxing effect on the skin | |
| JPH0796488B2 (en) | Graying agent |